Thermo Fisher Scientific (TMO) Competitors $485.49 -2.16 (-0.44%) As of 02:40 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock TMO vs. MEDP, A, AMN, DHR, HAE, MCK, QGEN, WST, MTD, and WATShould you be buying Thermo Fisher Scientific stock or one of its competitors? The main competitors of Thermo Fisher Scientific include Medpace (MEDP), Agilent Technologies (A), AMN Healthcare Services (AMN), Danaher (DHR), Haemonetics (HAE), McKesson (MCK), Qiagen (QGEN), West Pharmaceutical Services (WST), Mettler-Toledo International (MTD), and Waters (WAT). These companies are all part of the "medical" sector. Thermo Fisher Scientific vs. Its Competitors Medpace Agilent Technologies AMN Healthcare Services Danaher Haemonetics McKesson Qiagen West Pharmaceutical Services Mettler-Toledo International Waters Medpace (NASDAQ:MEDP) and Thermo Fisher Scientific (NYSE:TMO) are both large-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, dividends, media sentiment, institutional ownership, earnings, valuation and profitability. Is MEDP or TMO more profitable? Medpace has a net margin of 18.74% compared to Thermo Fisher Scientific's net margin of 15.24%. Medpace's return on equity of 67.66% beat Thermo Fisher Scientific's return on equity.Company Net Margins Return on Equity Return on Assets Medpace18.74% 67.66% 21.86% Thermo Fisher Scientific 15.24%16.82%8.38% Do analysts prefer MEDP or TMO? Medpace currently has a consensus target price of $422.27, suggesting a potential downside of 12.78%. Thermo Fisher Scientific has a consensus target price of $589.38, suggesting a potential upside of 21.59%. Given Thermo Fisher Scientific's stronger consensus rating and higher probable upside, analysts plainly believe Thermo Fisher Scientific is more favorable than Medpace.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Medpace 3 Sell rating(s) 11 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 1.94Thermo Fisher Scientific 0 Sell rating(s) 6 Hold rating(s) 16 Buy rating(s) 0 Strong Buy rating(s) 2.73 Do institutionals & insiders believe in MEDP or TMO? 78.0% of Medpace shares are held by institutional investors. Comparatively, 89.2% of Thermo Fisher Scientific shares are held by institutional investors. 20.3% of Medpace shares are held by company insiders. Comparatively, 0.3% of Thermo Fisher Scientific shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the media prefer MEDP or TMO? In the previous week, Thermo Fisher Scientific had 25 more articles in the media than Medpace. MarketBeat recorded 51 mentions for Thermo Fisher Scientific and 26 mentions for Medpace. Thermo Fisher Scientific's average media sentiment score of 1.36 beat Medpace's score of 0.71 indicating that Thermo Fisher Scientific is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medpace 13 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Thermo Fisher Scientific 45 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk & volatility, MEDP or TMO? Medpace has a beta of 1.44, indicating that its share price is 44% more volatile than the S&P 500. Comparatively, Thermo Fisher Scientific has a beta of 0.75, indicating that its share price is 25% less volatile than the S&P 500. Which has stronger valuation & earnings, MEDP or TMO? Thermo Fisher Scientific has higher revenue and earnings than Medpace. Thermo Fisher Scientific is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMedpace$2.11B6.45$404.39M$13.4535.99Thermo Fisher Scientific$42.88B4.27$6.34B$17.2928.04 SummaryThermo Fisher Scientific beats Medpace on 9 of the 16 factors compared between the two stocks. Get Thermo Fisher Scientific News Delivered to You Automatically Sign up to receive the latest news and ratings for TMO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TMO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TMO vs. The Competition Export to ExcelMetricThermo Fisher ScientificMED INSTRUMENTS IndustryMedical SectorNYSE ExchangeMarket Cap$183.05B$6.94B$5.83B$21.35BDividend Yield0.35%1.21%6.70%3.49%P/E Ratio28.0426.4775.6329.46Price / Sales4.2744.60464.7848.48Price / Cash16.4022.4325.7018.12Price / Book3.745.0311.454.59Net Income$6.34B$176.38M$3.28B$1.00B7 Day Performance-0.43%0.96%0.99%0.81%1 Month Performance5.07%4.43%10.86%5.22%1 Year Performance-21.87%9.49%59.11%16.63% Thermo Fisher Scientific Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TMOThermo Fisher Scientific4.974 of 5 stars$485.49-0.4%$589.38+21.4%-20.3%$183.39B$42.88B28.09125,000Positive NewsAnalyst DowngradeMEDPMedpace4.2763 of 5 stars$475.51+0.5%$406.60-14.5%+46.6%$13.36B$2.11B35.355,900Analyst ForecastAAgilent Technologies4.7669 of 5 stars$125.63+0.5%$139.25+10.8%-6.6%$35.69B$6.79B29.4917,900Positive NewsAMNAMN Healthcare Services4.4383 of 5 stars$20.77+3.6%$28.25+36.0%-54.1%$795.98M$2.98B-2.672,968Positive NewsDHRDanaher4.9877 of 5 stars$206.09+0.4%$247.61+20.1%-25.3%$147.57B$23.88B43.8563,000Positive NewsHAEHaemonetics4.8477 of 5 stars$54.63+0.5%$85.18+55.9%-26.2%$2.63B$1.36B16.712,820Positive NewsShort Interest ↑Analyst RevisionMCKMcKesson4.5949 of 5 stars$686.44+0.8%$725.10+5.6%+38.2%$85.38B$377.60B27.3745,000Positive NewsQGENQiagen4.6875 of 5 stars$46.53+0.9%$49.69+6.8%+10.1%$10.34B$2.04B27.495,765Positive NewsWSTWest Pharmaceutical Services4.9775 of 5 stars$247.18+0.7%$320.71+29.7%-14.8%$17.77B$2.96B37.0010,600Positive NewsMTDMettler-Toledo International4.1822 of 5 stars$1,302.74+1.5%$1,311.11+0.6%-4.4%$26.84B$3.87B32.9917,300Positive NewsWATWaters4.7122 of 5 stars$301.89+1.4%$378.73+25.5%-5.9%$17.97B$2.96B27.227,600Trending News Related Companies and Tools Related Companies Medpace Alternatives Agilent Technologies Alternatives AMN Healthcare Services Alternatives Danaher Alternatives Haemonetics Alternatives McKesson Alternatives Qiagen Alternatives West Pharmaceutical Services Alternatives Mettler-Toledo International Alternatives Waters Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:TMO) was last updated on 9/9/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredBuffett, Gates and Bezos Dumping StocksThe world's wealthiest individuals are making huge moves with their money. Warren Buffett just liquidated b...Banyan Hill Publishing | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredTurn $1K into $50K with This DeFi GemBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Thermo Fisher Scientific Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Thermo Fisher Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
